Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hejia Henry Wang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Reviews. Clinical Oncology|September 22, 2025
Neoantigen vaccines at the crossroads: lessons from AMPLIFY-201Hejia Henry Wang, Mark Yarchoan
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2019
Overcoming the Limitations of Sortase with Proximity-Based Sortase-Mediated Ligation (PBSL)Hejia Henry Wang, Andrew Tsourkas
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Cytosolic delivery of inhibitory antibodies with cationic lipidsHejia Henry Wang, Andrew Tsourkas
Cell|September 19, 2025
Multi-adjuvant personalized neoantigen vaccines: Fine-tuning anti-cancer T cellsHejia Henry Wang, Neeha Zaidi
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2019
Site-Specific C-Terminal Labeling of Recombinant Proteins with Proximity-Based Sortase-Mediated Ligation (PBSL)Hejia Henry Wang, Andrew Tsourkas
Angewandte Chemie (International Ed. in English)|April 5, 2017
Proximity-Based Sortase-Mediated LigationHejia Henry Wang, Burcin Altun, Kido Nwe, et al.
Molecular Pharmaceutics|February 28, 2022
Cytosolic Delivery of Small Protein Scaffolds Enables Efficient Inhibition of Ras and MycAlexander Chan, Hejia Henry Wang, Rebecca M Haley, et al.
Nature Communications|June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Clinical Oncology|September 22, 2025
Neoantigen vaccines at the crossroads: lessons from AMPLIFY-201Hejia Henry Wang, Mark Yarchoan
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2019
Overcoming the Limitations of Sortase with Proximity-Based Sortase-Mediated Ligation (PBSL)Hejia Henry Wang, Andrew Tsourkas
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Cytosolic delivery of inhibitory antibodies with cationic lipidsHejia Henry Wang, Andrew Tsourkas
Cell|September 19, 2025
Multi-adjuvant personalized neoantigen vaccines: Fine-tuning anti-cancer T cellsHejia Henry Wang, Neeha Zaidi
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2019
Site-Specific C-Terminal Labeling of Recombinant Proteins with Proximity-Based Sortase-Mediated Ligation (PBSL)Hejia Henry Wang, Andrew Tsourkas
Angewandte Chemie (International Ed. in English)|April 5, 2017
Proximity-Based Sortase-Mediated LigationHejia Henry Wang, Burcin Altun, Kido Nwe, et al.
Molecular Pharmaceutics|February 28, 2022
Cytosolic Delivery of Small Protein Scaffolds Enables Efficient Inhibition of Ras and MycAlexander Chan, Hejia Henry Wang, Rebecca M Haley, et al.
Nature Communications|June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Pageof 1